Merus to Participate in Upcoming Investor Conferences
UTRECHT, The Netherlands, 2016-08-31 13:00 CEST (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that the Company will participate in the following upcoming investor conferences:
- Ton Logtenberg, CEO, will present at the 2016 Credit Suisse Antibody Day on Wednesday, September 7 at 2:40 PM ET at Credit Suisse's offices at One Madison Avenue in New York City.
- Management will participate in investor meetings at Citi’s 11thAnnual Biotech Conference on Thursday, September 8 at the Mandarin Oriental in Boston.
A live webcast of the Credit Suisse presentation will be available on the Investor page of the Company's website. An archived presentation will be available for 90 days.
About Merus N.V.
Merus is a clinical-stage immuno-oncology company developing innovative full length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics® are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have several of the same features of conventional monoclonal antibodies, such as long half-life and low immunogenicity. Merus' lead bispecific antibody candidate, MCLA-128, is being evaluated in a Phase 1/2 clinical trial in Europe as a potential treatment for HER2-expressing solid tumors. Merus' second bispecific antibody candidate, MCLA-117, is being developed as a potential treatment for acute myeloid leukemia. The Company also has a pipeline of proprietary bispecific antibody candidates in preclinical development, including MCLA-158, which is designed to bind to cancer stem cells and is being developed as a potential treatment for colorectal cancer and other solid tumors, and Biclonics® designed to bind to various combinations of immunomodulatory molecules, including PD-1 and PD-L1.
Shelley Margetson - firstname.lastname@example.org
+31 (0)30 253 8800
Kimberly Minarovich - email@example.com
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
Magna International Inc.12.11.2018 23:06 | pressemeddelelse
TSX Accepts Notice of Intention to Make Normal Course Issuer Bid
Erytech Pharma S.A.12.11.2018 22:31 | pressemeddelelse
ERYTECH Reports Third Quarter 2018 Financial Results and Provides Business Update
Mitratech12.11.2018 14:02 | pressemeddelelse
Mitratech’s DataStore Helps Financial Services Clients Across the Globe Meet Regulatory Requirements, Reduce Risk and Improve Efficiency
Bombardier Transportation; Alstom12.11.2018 13:49 | pressemeddelelse
Bombardier-Alstom consortium to supply 153 additional AZUR metro cars for Montréal
Juniper Networks; World Robot Olympiad™ Association; LEGO® Education12.11.2018 11:01 | pressemeddelelse
Media Alert: Fifteenth World Robot Olympiad Finals Set in Thailand
Mash Group Oyj12.11.2018 10:18 | pressemeddelelse
Mash Group Plc Reports Interim Unaudited Q3 Financials, ended 30th September 2018
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum